Cite
HARVARD Citation
Qamar, A. et al. (2020). Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2°P-TIMI 50 trial. Vascular medicine. pp. 124-132. [Online].